Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02LSR
|
|||
| Former ID |
DIB015534
|
|||
| Drug Name |
SNK-882
|
|||
| Synonyms |
2-(2-Oxopyrrolidin-1-yl)-N-(perhydropyrrolizin-7a-ylmethyl)acetamide hydrochloride
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7] | Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H24ClN3O2
|
|||
| Canonical SMILES |
C1CC(=O)N(C1)CC(=O)NCC23CCCN2CCC3.Cl
|
|||
| InChI |
1S/C14H23N3O2.ClH/c18-12(10-16-7-1-4-13(16)19)15-11-14-5-2-8-17(14)9-3-6-14;/h1-11H2,(H,15,18);1H
|
|||
| InChIKey |
DSRRZZDDBKFTID-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 152221-12-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs. Curr Pharm Des. 2002;8(2):125-38. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.